Anaptysbio Inc

ANABStocksBiotechnologyUnited StatesNasdaqUSD

Price

$46.44

Today

-0.6%

YTD

-4.0%

About

AnaptysBio, Inc. is an American biopharmaceutical company engaged in the development of therapeutic antibody product candidates. It is focused on unmet medical needs in inflammation and it is known for its antibody generation technology in the biopharmaceutical industry. Operational in the biotechnology sector, AnaptysBio is distinguished for its use of a proprietary somatic hypermutation (SHM) platform to generate antibody therapeutics. It also has multiple collaborations with other biopharma companies, including GlaxoSmithKline. Diversify your virtual portfolio by following ANAB shares on eToro.

Price chart

Closing price history for ANAB (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)7.63

P/S (TTM)6.16

P/B (TTM)138.18

Market cap$1.47B

Cap tierSmall-cap

Industry avg P/E-2.16

Profitability

Gross margin98.96%

EBIT margin56.36%

Net margin833.97%

ROE-114.55%

ROA70.78%

Earnings & Revenue

Revenue (TTM)$237.61M

Revenue growth (1Y)+92.9%

EPS (TTM)$6.45

Free cash flow$18.07M

Total debt$269.59M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)0.86

Employees104

Next earnings3 Nov '26

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.